Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer
ConditionCancer of Pancreas
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Central Florida
About this trial
The goal of this research is to use chromatin immunoprecipitation, a method used to study protein-DNA interaction, as a tool to diagnose and prognose pancreatic ductal adenocarcinoma in human samples.
This is a Non-Human Subject Research study. All participants are de-identified.
Eligibility criteria
Qualifiers
18 years old or older
Pancreatic cancer patients
Disqualifiers
Children may not register
Persons who are unable to consent may not register
Trial design
Treatments tested in this trial
- Non-Human Subject Research study.
Treatment groups
24 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov